摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4’-(二甲胺基)苯基)-6-甲基苯并噻唑 | 10205-62-6

中文名称
2-(4’-(二甲胺基)苯基)-6-甲基苯并噻唑
中文别名
2-(4-(二甲基氨基)苯基)-6-甲基-苯并噻唑;2-(4-(二甲胺基)苯基)-6-甲基苯并噻唑
英文名称
N,N-dimethyl-4-(6-methylbenzo[d]thiazole-2-yl)aniline
英文别名
N,N-dimethyl-4-(6-methylbenzo[d]thiazol-2-yl)aniline;BTA-1;Benzenamine, N,N-dimethyl-4-(6-methyl-2-benzothiazolyl)-;N,N-dimethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline
2-(4’-(二甲胺基)苯基)-6-甲基苯并噻唑化学式
CAS
10205-62-6
化学式
C16H16N2S
mdl
——
分子量
268.382
InChiKey
OEOPVJYUCSQVMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    204-206 °C(lit.)
  • 沸点:
    428.8±47.0 °C(Predicted)
  • 密度:
    1.188±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    遵照规格使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    44.4
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2934999090

SDS

SDS:9d06e1640b3b4020449b3489ea76e99b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Metal-Free Synthesis of 2-Arylbenzothiazoles from Aldehydes, Amines, and Thiocyanate
    作者:Amrita Dey、Alakananda Hajra
    DOI:10.1021/acs.orglett.9b00245
    日期:2019.3.15
    A highly efficient method for the synthesis of 2-arylbenzothiazoles has been developed using readily available aromatic amines, benzaldehydes, and NH4SCN as a sulfur source. A library of 2-arylbenzothiazoles with wide functional group compatibility has been synthesized in good yields through iodine-mediated oxidative annulation.
    已经开发了一种高效的合成2-芳基苯并噻唑的方法,该方法使用容易获得的芳族胺,苯甲醛和NH 4 SCN作为硫源。通过碘介导的氧化环化反应,以高收率合成了具有广泛官能团相容性的2-芳基苯并噻唑文库。
  • METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20190290778A1
    公开(公告)日:2019-09-26
    Provided herein, inter alia, are methods and compounds for targeted autophagy.
    本文提供了针对靶向自噬的方法和化合物。
  • (3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASES
    申请人:Chi Dae-Yoon
    公开号:US20120214994A1
    公开(公告)日:2012-08-23
    The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases. The aryl derivatives of the present invention are (3-fluoro-2-hydroxy)propyl-functionalized to increase the polarity thereof, and therefore the drugs containing the aryl derivatives can easily permeate into the cerebrovascular membrane, thus increasing the effectiveness of the drugs. As the aryl derivatives of the present invention strongly bind to β-amyloid, the aryl derivatives, when labeled with radioisotope, can be used as a diagnostic agent for non-invasively diagnosing early Alzheimer's disease. Further, the aryl derivatives of the present invention bind to low molecular β-amyloid peptide conjugates to inhibit the generation of malignant high molecular β-amyloid plaque, and thus can be effectively used as a therapeutic agent for neurodegenerative brain diseases such as Alzheimer's disease.
    本发明涉及(3-氟-2-羟基)丙基官能化芳基衍生物或其药用可接受的盐,以及制备该衍生物的方法,以及含有该衍生物作为活性成分的药物组合物,用于诊断或治疗神经退行性脑疾病。本发明的芳基衍生物经(3-氟-2-羟基)丙基官能化以增加其极性,因此含有该芳基衍生物的药物可以轻松渗透到脑血管膜中,从而增加药物的有效性。由于本发明的芳基衍生物与β-淀粉样蛋白结合强,因此当该芳基衍生物标记放射性同位素时,可用作无创诊断早期阿尔茨海默病的诊断剂。此外,本发明的芳基衍生物与低分子量β-淀粉样肽结合以抑制恶性高分子量β-淀粉样斑块的生成,因此可以有效用作治疗阿尔茨海默病等神经退行性脑疾病的治疗剂。
  • USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME
    申请人:Nihon Medi-Physics Co., Ltd.
    公开号:EP2218463A1
    公开(公告)日:2010-08-18
    The invention provides a reagent for detecting amyloid in a biological tissue which can be detect amyloid in vitro and in vivo with high sensitivity using a compound which has affinity with amyloid and is suppressed in toxicity such as mutagenicity. The reagent for detecting amyloid deposited in a biological tissue comprises a compound represented by the following formula (1) or a salt thereof: wherein A1, A2, A3 and A4 independently represents a carbon or nitrogen; R1 is a halogen substituent; R2 is a halogen substituent; and m is an integer or 0 to 2, provided that at least one of R1 and R2 is a radioactive halogen substituent, at least one of A1, A2, A3 and A4 represents a carbon, and R1 binds to a carbon represented by A1, A2, A3 and A4.
    该发明提供了一种用于检测生物组织中淀粉样蛋白的试剂,可以利用一种与淀粉样蛋白亲和力强且在毒性方面受到抑制(如致突变性)的化合物,在体外和体内高灵敏度地检测淀粉样蛋白。用于检测生物组织中沉积的淀粉样蛋白的试剂包括下式(1)所表示的化合物或其盐:其中A1、A2、A3和A4独立地代表碳或氮;R1是卤素取代基;R2是卤素取代基;m是整数或0到2,但至少R1和R2中的一个是放射性卤素取代基,A1、A2、A3和A4中至少一个代表碳,且R1与A1、A2、A3和A4所代表的碳结合。
  • FLUORINATED BENZOTHIAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND IMAGING AGENT FOR DIAGNOSING ALTZHEIMER'S DISEASE USING THE SAME
    申请人:Kim Sang Eun
    公开号:US20110250136A1
    公开(公告)日:2011-10-13
    The present invention relates to fluorinated benzothiazole derivatives, a preparation method thereof, and an imaging agent for diagnosing Alzheimer's disease using the same, and more particularly to fluorinated benzothiazole derivatives represented by Chemical Formula 1, derivatives of Chemical Formula 2 as a starting material for preparation thereof, a preparation method thereof, and an imaging agent for diagnosing Alzheimer's disease using fluorinated benzothiazole derivatives with a strong binding force to beta-amyloid plaque, which is a kind of biomarker for Alzheimer's disease. According to the present invention, fluorine-labeled benzothiazole derivatives, which have been difficult to synthesize by conventional methods, may be obtained by simple processes and the thus-obtained benzothiazole derivatives may be useful in diagnosing the presence and severity of Alzheimer's disease.
    本发明涉及氟代苯并噻唑衍生物,其制备方法以及利用该衍生物诊断阿尔茨海默病的成像剂,更具体地涉及化学式1所代表的氟代苯并噻唑衍生物,化学式2的衍生物作为其制备的起始材料,其制备方法,以及利用具有强结合力与β-淀粉样斑块(阿尔茨海默病的一种生物标志物)的氟代苯并噻唑衍生物诊断阿尔茨海默病的成像剂。根据本发明,通过简单的方法可获得传统方法难以合成的氟标记的苯并噻唑衍生物,所获得的苯并噻唑衍生物可用于诊断阿尔茨海默病的存在和严重程度。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(1Z)-1-(3-乙基-5-羟基-2(3H)-苯并噻唑基)-2-丙酮 齐拉西酮砜 阳离子蓝NBLH 阳离子荧光黄4GL 锂2-(4-氨基苯基)-5-甲基-1,3-苯并噻唑-7-磺酸酯 铜酸盐(4-),[2-[2-[[2-[3-[[4-氯-6-[乙基[4-[[2-(硫代氧代)乙基]磺酰]苯基]氨基]-1,3,5-三嗪-2-基]氨基]-2-(羟基-kO)-5-硫代苯基]二氮烯基-kN2]苯基甲基]二氮烯基-kN1]-4-硫代苯酸根(6-)-kO]-,(1:4)氢,(SP-4-3)- 铜羟基氟化物 钾2-(4-氨基苯基)-5-甲基-1,3-苯并噻唑-7-磺酸酯 钠3-(2-{(Z)-[3-(3-磺酸丙基)-1,3-苯并噻唑-2(3H)-亚基]甲基}[1]苯并噻吩并[2,3-d][1,3]噻唑-3-鎓-3-基)-1-丙烷磺酸酯 邻氯苯骈噻唑酮 西贝奈迪 螺[3H-1,3-苯并噻唑-2,1'-环戊烷] 螺[3H-1,3-苯并噻唑-2,1'-环己烷] 葡萄属英A 草酸;N-[1-[4-(2-苯基乙基)哌嗪-1-基]丙-2-基]-2-丙-2-基氧基-1,3-苯并噻唑-6-胺 苯酰胺,N-2-苯并噻唑基-4-(苯基甲氧基)- 苯酚,3-[[2-(三苯代甲基)-2H-四唑-5-基]甲基]- 苯胺,N-(3-苯基-2(3H)-苯并噻唑亚基)- 苯碳杂氧杂脒,N-1,2-苯并异噻唑-3-基- 苯甲基2-甲基哌啶-1,2-二羧酸酯 苯并噻唑正离子,2-[3-(1,3-二氢-1,3,3-三甲基-2H-吲哚-2-亚基)-1-丙烯-1-基]-3-乙基-,碘化(1:1) 苯并噻唑正离子,2-[(2-乙氧基-2-羰基乙基)硫代]-3-甲基-,溴化 苯并噻唑啉 苯并噻唑-d4 苯并噻唑-6-腈 苯并噻唑-5-羧酸 苯并噻唑-5-硼酸频哪醇酯 苯并噻唑-4-醛 苯并噻唑-4-乙酸 苯并噻唑-2-磺酸钠 苯并噻唑-2-磺酸 苯并噻唑-2-磺酰氟 苯并噻唑-2-甲醛 苯并噻唑-2-甲酸 苯并噻唑-2-甲基甲胺 苯并噻唑-2-基磺酰氯 苯并噻唑-2-基叠氮化物 苯并噻唑-2-基-邻甲苯-胺 苯并噻唑-2-基-己基-胺 苯并噻唑-2-基-(4-氯-苯基)-胺 苯并噻唑-2-基-(4-氟-苯基)-胺 苯并噻唑-2-基-(4-乙氧基-苯基)-胺 苯并噻唑-2-基-(2-甲氧基-苯基)-胺 苯并噻唑-2-基-(2,6-二甲基-苯基)-胺 苯并噻唑-2-基(对甲苯基)甲醇 苯并噻唑-2-乙酸甲酯 苯并噻唑-2-乙腈 苯并噻唑-2(3H)-酮N2-[1-(吡啶-4-基)乙亚基]腙 苯并噻唑-2 - 丙基 苯并噻唑,6-(3-乙基-2-三氮烯基)-2-甲基-(8CI)